Cell & Gene Therapy International Europe 2027

Cell & Gene Therapy International Europe is a Berlin conference and exhibition on developing, manufacturing and commercializing cell and gene therapies. It's attended by biotech and pharma executives, scientists, manufacturing and regulatory specialists.

Official site

Checked November 6, 2026

Reported attendance

200+

global scientists · 2025

Reported exhibitors

Not published

How these are counted ↓

About Cell & Gene Therapy International Europe 2027

Cell & Gene Therapy International Europe is Informa Connect's conference and exhibition on making cell and gene therapies at commercial scale. It's aimed at therapy developers, manufacturing and analytical teams, regulatory specialists and investors. The latest edition ran from 3 to 5 November 2026 at Hotel Palace Berlin. The organizer invites visitors to sign up for 2027 updates, but it hasn't announced 2027 dates or a venue yet. It reported 200+ attendees from 150+ companies at the 2025 meeting.

Source: informaconnect.com

What happens at Cell & Gene Therapy International Europe

The event combines a conference, an exhibit hall and partnering meetings over three days. The 2026 agenda opened on 3 November with a full-day workshop on manufacturing tech transfer. The main conference ran on 4 and 5 November.

Day one of the 2026 conference started with a keynote plenary and a keynote investor panel. Parallel streams then covered cell therapy manufacturing and analytics, and gene therapy manufacturing and analytics. A networking reception in the exhibit hall closed the day.

Day two added innovation showcases for young cell therapy and gene therapy companies, plus poster viewing. During lunch, Live Labs offered 10-minute product demos at exhibitor booths.

In 2026, two co-located events shared the venue. They were Exosomes Europe and LNPs Europe, which covers lipid nanoparticle delivery. The organizer hasn't said whether the 2027 program keeps the same format.

What's new at Cell & Gene Therapy International Europe 2027

The organizer hasn't announced anything new for 2027 yet. Its event site only offers a sign-up for 2027 updates.

The 2026 edition moved from December to November and to a new Berlin venue. Evotec's 2025 event page shows the previous edition ran from 1 to 3 December 2025. The Start-Up Zone and the exosome and LNP tracks were new in 2026.

Related events on this site include BioProcess International Europe 2027, BIO-Europe Spring 2027 and BIO-Europe 2026.

Who attends Cell & Gene Therapy International Europe

Most attendees work at companies developing cell and gene therapies. The organizer says the event suits professionals in development, manufacturing, analytics, regulatory affairs and commercialization. It names CEOs, CSOs, CBOs, CMOs, scientists, engineers and consultants.

For the 2025 meeting, the organizer reported 200+ scientists, executives and technology leaders. They came from 150+ companies, and 65% of those companies were cell and gene therapy developers.

The organizer hasn't published attendance figures for the November 2026 edition. Before the show, it promoted 70+ speakers, 100+ companies and 20+ exhibitors. Those were targets, not results.

The 2026 program also drew investors and regulators. Venture firms sat on the keynote investor panel, and the Alliance for Regenerative Medicine spoke on European regulation.

Attendance and exhibitors by year

As the organizer reports them. What's counted varies between events, so compare with care.

EditionAttendance
2025

200+global scientists, executives and technology leaders (organizer figure)Organizer's figure for the 2025 meeting in Berlininformaconnect.com ↗

Companies exhibiting and speaking at Cell & Gene Therapy International Europe 2026

No companies have been announced for 2027 yet. The sponsor page named six sponsors and exhibitors, three media partners and two promotional participants for 2026. Speakers came from big pharma, commercial cell and gene therapy companies, and start-ups.

Partners (5)BioPharma Asia, European Pharmaceutical Manufacturer, Gene Therapy Net and 2 more
Exhibitors (6)Catalent, Chromagenix, Clean Biologics and 3 more
Speakers' companies (12)Orchard Therapeutics, Legend Biotech, Johnson & Johnson Innovative Medicine and 9 more
Attending (2)Evotec, Eli Lilly

Big pharma names on the 2026 agenda included Novartis, Johnson & Johnson Innovative Medicine, Bayer, UCB and CSL Behring. Commercial therapy companies included Legend Biotech, Autolus Therapeutics and Orchard Therapeutics.

Exhibitors at Cell & Gene Therapy International Europe

The organizer hasn't published an exhibitor count for 2026 or opened 2027 exhibitor bookings on its site. Its sponsor page named six sponsors and exhibitors for 2026 on 25 October 2026, by our count. They were Catalent, Chromagenix, Clean Biologics, NanoEntek EU, NanoFcm and Terumo BCT Europe.

A Start-Up Zone was new on the 2026 exhibition floor. The Full Package cost £3,000 plus VAT. It included a 2 by 2 meter tabletop, a quick pitch and one main conference pass.

The 2026 Full Package Plus cost £4,500 plus VAT and included two passes. Applicants had to be under five years old with fewer than ten employees.

Sponsors and exhibitors get Lead Insights, a lead scoring and reporting dashboard for their delegate interactions. Compare options in our guides to lead retrieval apps and meeting scheduling software.

Sponsors and partners at Cell & Gene Therapy International Europe

Sponsorship is sold as custom packages, according to the homepage FAQ. The Why Sponsor page lists speaking sessions, branded items, exhibit booths and private meeting rooms.

The sponsor page listed BioPharma Asia, European Pharmaceutical Manufacturer and Gene Therapy Net as 2026 media partners. Bio Partner and MaxCyte were listed as 2026 promotional participants.

The sponsorship prospectus sits behind a request form on the organizer's site. For tools that track packages and deliverables, see our event sponsorship software guide.

The event's tech

We couldn't identify a third-party registration platform on the event's website.

Which platforms run B2B event registration →

Cell & Gene Therapy International Europe attendee list, exhibitor list and sponsor list

The organizer doesn't publish a full attendee list on its site. Its snapshot attendee list sits behind a sign-up form.

Registered attendees get the full attendee list inside the ConnectMe app, with messaging and meeting requests. The registration page says this covers both in-person and digital attendees.

Exhibitors, sponsors and media partners appear on the official sponsors and exhibitors page. The site doesn't carry a separate exhibitor directory or a public floor plan.

The organizer warns about housing companies that aren't affiliated with the event. It says official hotel links appear only on its own website. Read how to find who's attending an event and our roundup of event intelligence platforms.

See who's attending Cell & Gene Therapy International Europe

Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending

Speakers at Cell & Gene Therapy International Europe 2027

Cell & Gene Therapy International Europe hasn't announced its 2027 speakers yet. The organizer's event site offers 2027 updates by email sign-up.

Cell & Gene Therapy International Europe hasn't announced its 2027 speakers yet. Below is who spoke at past editions.

At the 2026 edition, Gunther Busam of Orchard Therapeutics gave the opening plenary talk on 4 November. Marion Hitchcock of Bayer chaired the plenary.

The 2026 keynote investor panel featured Novo Nordisk Foundation Cellerator, LongeVC, High-Tech Gründerfonds, Avant Bio and Advantary Capital Partners. Sarah Snykers of Legend Biotech and Rutger Douma of Johnson & Johnson spoke in the manufacturing tracks.

On 5 November 2026, Simone Zanetti of CSL Behring presented a Hemgenix case study. Paolo Morgese of the Alliance for Regenerative Medicine covered European regulation.

Two innovation showcases featured young companies in 2026. Presenters included Captain T Cell, ImmunoKey, NeutroGen Therapeutics, Ikarovec, Kindling Bio, EpiBlok Therapeutics and CREATe Therapeutics. Researchers could add a scientific poster to an All Access pass.

Who spoke at Cell & Gene Therapy International Europe 2026 (38)

Dates, venue and getting there

Dates and a venue for 2027 aren't announced yet. The organizer's event site thanks 2026 attendees and offers sign-up for 2027 updates.

The 2026 edition ran from 3 to 5 November 2026 at Hotel Palace Berlin. That hotel is at Budapester Straße 45 in the city's west. The visitBerlin convention office lists 2,600 square meters of event space and 18 function rooms.

The 2025 edition took place at the Mercure Hotel MOA in Berlin from 1 to 3 December 2025. Both of the last two editions were in Berlin.

Tickets and registration for Cell & Gene Therapy International Europe

Registration is paid and priced by company type. Prices for 2027 aren't published yet. In October 2026, the Biopharma, Academic and Government conference pass cost £1,199 plus 19% VAT. Adding the workshop raised it to £1,399 plus VAT.

For 2026, biopharma rates required a cell or gene therapy product in the pipeline. CDMOs, CROs, suppliers and sales staff had to book the Service Provider rate.

Start-up rates applied to therapy developers under five years old with fewer than ten employees. Groups of three to four got 10% off, and groups of five to nine got 15% off.

Passes included 12 months of on-demand access to recorded main conference talks. A Digital Experience pass covered virtual attendance.

Frequently asked questions

When is Cell & Gene Therapy International Europe 2027?
Dates for 2027 aren't announced yet. The organizer offers sign-up for 2027 updates. The 2026 edition ran from 3 to 5 November 2026 in Berlin.
Where is Cell & Gene Therapy International Europe held?
The last two editions were in Berlin. The 2026 edition was at Hotel Palace Berlin, and the 2025 edition was at the Mercure Hotel MOA. The 2027 venue isn't announced.
How many people attend Cell & Gene Therapy International Europe?
The organizer reported 200+ attendees from 150+ companies at the 2025 meeting. It said 65% of those companies were therapy developers. It hasn't published 2026 figures.
Who organizes Cell & Gene Therapy International Europe?
Informa Connect, a division of Informa PLC, organizes it. Its BioProcess International brand also lists the event.
Who attends Cell & Gene Therapy International Europe?
Mostly people from cell and gene therapy developers. The organizer names CEOs, CSOs, scientists, engineers and consultants in development, manufacturing, analytics, regulatory and commercial roles.
Which companies exhibit at Cell & Gene Therapy International Europe?
The sponsor page listed Catalent, Chromagenix, Clean Biologics, NanoEntek EU, NanoFcm and Terumo BCT Europe for 2026. No 2027 exhibitors are announced yet.
Who's speaking at Cell & Gene Therapy International Europe 2027?
The 2027 speakers aren't announced yet. In 2026, speakers included Gunther Busam of Orchard Therapeutics, Sarah Snykers of Legend Biotech and Simone Zanetti of CSL Behring, per the 2026 speakers page.
Is there an attendee list for Cell & Gene Therapy International Europe?
There's no public attendee list. Registered attendees can browse it in the ConnectMe app, and a snapshot list sits behind a sign-up form.
How much does Cell & Gene Therapy International Europe cost?
Prices for 2027 aren't published. In October 2026, the biopharma, academic and government pass cost £1,199 plus VAT, or £1,399 with the workshop.
How can I exhibit or sponsor at Cell & Gene Therapy International Europe?
Sponsorship is sold as custom packages through the Why Sponsor page. In 2026, young companies could apply for a Start-Up Zone tabletop from £3,000 plus VAT.
Is Cell & Gene Therapy International Europe co-located with other events?
In 2026 it was co-located with Exosomes Europe and LNPs Europe at Hotel Palace Berlin. The organizer hasn't confirmed the 2027 format.